#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukaemia Myotonia Leiomyosarcoma Crohn's disease Brain abscess Uveal melanoma Hepatoblastoma Non-Hodgkin's lymphoma refractory Cognitive disorder Glycogen storage disease type V Langerhans cell sarcoma Duchenne muscular dystrophy gene carrier Severe myoclonic epilepsy of infancy Hyperchylomicronaemia Testicular leiomyosarcoma More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Diagnostics Congenital generalised lipodystrophy Leiomyosarcoma metastatic – Basic Information MELAS syndrome – Life with Disease Hereditary angioedema Lymphatic malformation – Treatment Mantle cell lymphoma stage III Pulmonary fibrosis – Basic Information Retinitis pigmentosa – Treatment Propionic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivermectin Dexamethasone Azd8630 Dasatinib Methotrexate Sodium Betamethasone Cannabis Sativa Flower Semaglutide Imipenem Icatibant Betaxolol Felzartamab Meloxicam Linrodostat Mesilate Abrocitinib 4-Hydroxy-N-Desmethyltamoxifen APAZUNERSEN IBANDRONIC ACID Deutivacaftor Ranibizumab More therapies…

    Learn about Your Condition

    Graft versus host disease Colon cancer stage III Breast cancer stage IV COVID-19 Hysterectomy Endometrial cancer Mumps Endometrial cancer stage I Glioblastoma multiforme Colon cancer Thrombotic microangiopathy Trisomy 21 Chronic lymphocytic leukaemia Alcoholism Procedural hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dyslipidaemia

  • Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bempedoic Acid
    • Obicetrapib
    Czechia Germany Italy The Netherlands Poland Slovakia +1

  • Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Dyslipidaemia
    Investigated Drugs:
    • Atorvastatin
    • Rosuvastatin
    • Inclisiran
    France Germany Hungary Poland Spain

  • Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rbd5044 Sodium
    Poland Sweden

  • Study of Rosuvastatin Effects on Coronary Artery Plaque Volume in Patients with Stable Chest Pain Using CT Imaging

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Dyslipidaemia
    • Coronary artery disease
    Investigated Drugs:
    • Rosuvastatin
    Hungary

  • Study Comparing Rosuvastatin and Fenofibrate with Pravastatin and Fenofibrate for Patients with Mixed Dyslipidemia at High Risk of Heart Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Fenofibrate
    • Pravastatin Sodium
    • Rosuvastatin
    Greece

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!